HEADER TRANSFERASE 30-MAR-11 2YER TITLE SYNTHESIS AND EVALUATION OF TRIAZOLONES AS CHECKPOINT KINASE 1 TITLE 2 INHIBITORS COMPND MOL_ID: 1; COMPND 2 MOLECULE: SERINE/THREONINE-PROTEIN KINASE CHK1; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: CHK1KD, RESIDUES 1-276; COMPND 5 SYNONYM: CHK1 CHECKPOINT KINASE; COMPND 6 EC: 2.7.11.1; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 6 EXPRESSION_SYSTEM_COMMON: FALL ARMYWORM; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 8 EXPRESSION_SYSTEM_CELL_LINE: SF9 KEYWDS TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR J.A.READ,J.BREED,H.HAYE,E.MCCALL,A.VALLENTINE,A.WHITE,L.OTTERBEIN REVDAT 3 08-MAY-24 2YER 1 REMARK REVDAT 2 04-APR-18 2YER 1 REMARK REVDAT 1 14-MAR-12 2YER 0 JRNL AUTH V.OZA,S.ASHWELL,P.BRASSIL,J.BREED,J.EZHUTHACHAN,C.DENG, JRNL AUTH 2 M.GRONDINE,C.HORN,D.LIU,P.LYNE,N.NEWCOMBE,M.PASS,J.READ, JRNL AUTH 3 M.SU,D.TOADER,D.YU,Y.YU,S.ZABLUDOFF JRNL TITL SYNTHESIS AND EVALUATION OF TRIAZOLONES AS CHECKPOINT KINASE JRNL TITL 2 1 INHIBITORS. JRNL REF BIOORG.MED.CHEM.LETT. V. 22 2330 2012 JRNL REFN ISSN 0960-894X JRNL PMID 22342147 JRNL DOI 10.1016/J.BMCL.2012.01.043 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH V.OZA,S.ASHWELL,P.BRASSIL,J.BREED,C.DENG,J.EZHUTHACHAN, REMARK 1 AUTH 2 H.HAYE,C.HORN,J.JANETKA,P.LYNE,N.NEWCOMBE,L.OTTERBIEN, REMARK 1 AUTH 3 M.PASS,J.READ,S.ROSWELL,M.SU,D.TOADER,D.YU,Y.YU,A.VALENTINE, REMARK 1 AUTH 4 P.WEBBORN,A.WHITE,S.ZABLUDOFF,X.ZHENG REMARK 1 TITL DISCOVERY OF A NOVEL CLASS OF TRIAZOLONES AS CHECKPOINT REMARK 1 TITL 2 KINASE INHIBITORS--HIT TO LEAD EXPLORATION. REMARK 1 REF BIOORG.MED.CHEM.LETT. V. 20 5133 2010 REMARK 1 REFN ISSN 0960-894X REMARK 1 PMID 20673630 REMARK 1 DOI 10.1016/J.BMCL.2010.07.015 REMARK 2 REMARK 2 RESOLUTION. 1.83 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.5.0110 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.83 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 57.94 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 83.9 REMARK 3 NUMBER OF REFLECTIONS : 21599 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.147 REMARK 3 R VALUE (WORKING SET) : 0.145 REMARK 3 FREE R VALUE : 0.175 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.900 REMARK 3 FREE R VALUE TEST SET COUNT : 1121 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.83 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.88 REMARK 3 REFLECTION IN BIN (WORKING SET) : 239 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 12.47 REMARK 3 BIN R VALUE (WORKING SET) : 0.1550 REMARK 3 BIN FREE R VALUE SET COUNT : 7 REMARK 3 BIN FREE R VALUE : 0.3570 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2153 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 50 REMARK 3 SOLVENT ATOMS : 407 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 7.58 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 14.43 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.30000 REMARK 3 B22 (A**2) : 0.60000 REMARK 3 B33 (A**2) : -0.30000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.139 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.120 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.063 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 4.343 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.957 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.940 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 2257 ; 0.007 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): 1555 ; 0.001 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 3055 ; 1.280 ; 1.982 REMARK 3 BOND ANGLES OTHERS (DEGREES): 3785 ; 1.126 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 267 ; 5.343 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 106 ;34.654 ;24.340 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 384 ;11.146 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 14 ;14.696 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 327 ; 0.095 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 2497 ; 0.004 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): 450 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1340 ; 0.409 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 534 ; 0.075 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 2172 ; 0.805 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 917 ; 1.233 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 883 ; 2.075 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 2 A 269 REMARK 3 ORIGIN FOR THE GROUP (A): 13.9497 33.9223 16.2646 REMARK 3 T TENSOR REMARK 3 T11: 0.0126 T22: 0.0005 REMARK 3 T33: 0.0141 T12: 0.0025 REMARK 3 T13: 0.0061 T23: 0.0011 REMARK 3 L TENSOR REMARK 3 L11: 0.2471 L22: 0.0649 REMARK 3 L33: 0.3310 L12: 0.0357 REMARK 3 L13: 0.0812 L23: -0.0244 REMARK 3 S TENSOR REMARK 3 S11: -0.0022 S12: -0.0028 S13: 0.0154 REMARK 3 S21: 0.0040 S22: 0.0016 S23: -0.0012 REMARK 3 S31: -0.0193 S32: -0.0056 S33: 0.0006 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : BABINET MODEL WITH MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS. REMARK 4 REMARK 4 2YER COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 30-MAR-11. REMARK 100 THE DEPOSITION ID IS D_1290047877. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 01-OCT-09 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU FR-E REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : NI FILTER REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : RIGAKU CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 22780 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.830 REMARK 200 RESOLUTION RANGE LOW (A) : 103.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 83.9 REMARK 200 DATA REDUNDANCY : 5.600 REMARK 200 R MERGE (I) : 0.03000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 36.5000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.83 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.93 REMARK 200 COMPLETENESS FOR SHELL (%) : 25.0 REMARK 200 DATA REDUNDANCY IN SHELL : 1.70 REMARK 200 R MERGE FOR SHELL (I) : 0.05000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 11.90 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 48.74 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.40 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PH 7.5 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 20.58000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 51.75000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 34.96000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 51.75000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 20.58000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 34.96000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 LYS A 270 REMARK 465 LYS A 271 REMARK 465 GLY A 272 REMARK 465 ALA A 273 REMARK 465 LYS A 274 REMARK 465 ARG A 275 REMARK 465 PRO A 276 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLU A 17 CG CD OE1 OE2 REMARK 470 ARG A 44 CD NE CZ NH1 NH2 REMARK 470 GLU A 50 CG CD OE1 OE2 REMARK 470 LYS A 53 CE NZ REMARK 470 LYS A 180 CG CD CE NZ REMARK 470 ASP A 213 CG OD1 OD2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 NE2 GLN A 80 O HOH A 2150 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 VAL A 35 CG1 - CB - CG2 ANGL. DEV. = 11.4 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 130 45.51 -146.31 REMARK 500 ASP A 148 98.70 75.35 REMARK 500 ASN A 158 -118.27 52.80 REMARK 500 LEU A 246 55.84 -91.38 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A2014 DISTANCE = 6.25 ANGSTROMS REMARK 525 HOH A2029 DISTANCE = 6.49 ANGSTROMS REMARK 525 HOH A2043 DISTANCE = 5.91 ANGSTROMS REMARK 525 HOH A2100 DISTANCE = 5.95 ANGSTROMS REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE TQ1 A 1270 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 1271 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 1272 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 1273 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 1274 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 1275 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 1276 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 1277 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1IA8 RELATED DB: PDB REMARK 900 THE 1.7 A CRYSTAL STRUCTURE OF HUMAN CELL CYCLE CHECKPOINTKINASE REMARK 900 CHK1 REMARK 900 RELATED ID: 1NVQ RELATED DB: PDB REMARK 900 THE COMPLEX STRUCTURE OF CHECKPOINT KINASE CHK1/UCN-01 REMARK 900 RELATED ID: 1NVR RELATED DB: PDB REMARK 900 THE COMPLEX STRUCTURE OF CHECKPOINT KINASECHK1/ STAUROSPORINE REMARK 900 RELATED ID: 1NVS RELATED DB: PDB REMARK 900 THE COMPLEX STRUCTURE OF CHECKPOINT KINASE CHK1/SB218078 REMARK 900 RELATED ID: 1ZLT RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF CHK1 COMPLEXED WITH A HYMENALDISINEANALOG REMARK 900 RELATED ID: 1ZYS RELATED DB: PDB REMARK 900 CO-CRYSTAL STRUCTURE OF CHECKPOINT KINASE CHK1 WITH APYRROLO- REMARK 900 PYRIDINE INHIBITOR REMARK 900 RELATED ID: 2AYP RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF CHK1 WITH AN INDOL INHIBITOR REMARK 900 RELATED ID: 2BR1 RELATED DB: PDB REMARK 900 STRUCTURE-BASED DESIGN OF NOVEL CHK1 INHIBITORS: INSIGHTS INTO REMARK 900 HYDROGEN BONDING AND PROTEIN-LIGAND AFFINITY REMARK 900 RELATED ID: 2BRB RELATED DB: PDB REMARK 900 STRUCTURE-BASED DESIGN OF NOVEL CHK1 INHIBITORS: INSIGHTS INTO REMARK 900 HYDROGEN BONDING AND PROTEIN-LIGAND AFFINITY REMARK 900 RELATED ID: 2BRG RELATED DB: PDB REMARK 900 STRUCTURE-BASED DESIGN OF NOVEL CHK1 INHIBITORS: INSIGHTS INTO REMARK 900 HYDROGEN BONDING AND PROTEIN-LIGAND AFFINITY REMARK 900 RELATED ID: 2BRH RELATED DB: PDB REMARK 900 STRUCTURE-BASED DESIGN OF NOVEL CHK1 INHIBITORS: INSIGHTS INTO REMARK 900 HYDROGEN BONDING AND PROTEIN-LIGAND AFFINITY REMARK 900 RELATED ID: 2BRM RELATED DB: PDB REMARK 900 STRUCTURE-BASED DESIGN OF NOVEL CHK1 INHIBITORS: INSIGHTS INTO REMARK 900 HYDROGEN BONDING AND PROTEIN-LIGAND AFFINITY REMARK 900 RELATED ID: 2BRN RELATED DB: PDB REMARK 900 STRUCTURE-BASED DESIGN OF NOVEL CHK1 INHIBITORS: INSIGHTS INTO REMARK 900 HYDROGEN BONDING AND PROTEIN-LIGAND AFFINITY REMARK 900 RELATED ID: 2BRO RELATED DB: PDB REMARK 900 STRUCTURE-BASED DESIGN OF NOVEL CHK1 INHIBITORS: INSIGHTS INTO REMARK 900 HYDROGEN BONDING AND PROTEIN-LIGAND AFFINITY REMARK 900 RELATED ID: 2C3J RELATED DB: PDB REMARK 900 IDENTIFICATION OF A BURIED POCKET FOR POTENT AND SELECTIVE REMARK 900 INHIBITION OF CHK1: PREDICTION AND VERIFICATION REMARK 900 RELATED ID: 2C3K RELATED DB: PDB REMARK 900 IDENTIFICATION OF A BURIED POCKET FOR POTENT AND SELECTIVE REMARK 900 INHIBITION OF CHK1: PREDICTION AND VERIFICATION REMARK 900 RELATED ID: 2C3L RELATED DB: PDB REMARK 900 IDENTIFICATION OF A BURIED POCKET FOR POTENT AND SELECTIVE REMARK 900 INHIBITION OF CHK1: PREDICTION AND VERIFICATION REMARK 900 RELATED ID: 2CGU RELATED DB: PDB REMARK 900 IDENTIFICATION OF CHEMICALLY DIVERSE CHK1 INHIBITORS BY RECEPTOR- REMARK 900 BASED VIRTUAL SCREENING REMARK 900 RELATED ID: 2CGV RELATED DB: PDB REMARK 900 IDENTIFICATION OF CHEMICALLY DIVERSE CHK1 INHIBITORS BY RECEPTOR- REMARK 900 BASED VIRTUAL SCREENING REMARK 900 RELATED ID: 2CGW RELATED DB: PDB REMARK 900 IDENTIFICATION OF CHEMICALLY DIVERSE CHK1 INHIBITORS BY RECEPTOR- REMARK 900 BASED VIRTUAL SCREENING REMARK 900 RELATED ID: 2CGX RELATED DB: PDB REMARK 900 IDENTIFICATION OF CHEMICALLY DIVERSE CHK1 INHIBITORS BY RECEPTOR- REMARK 900 BASED VIRTUAL SCREENING REMARK 900 RELATED ID: 2WMQ RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF CHECKPOINT KINASE 1 (CHK1) IN COMPLEX WITH REMARK 900 INHIBITORS REMARK 900 RELATED ID: 2WMR RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF CHECKPOINT KINASE 1 (CHK1) IN COMPLEX WITH REMARK 900 INHIBITORS REMARK 900 RELATED ID: 2WMS RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF CHECKPOINT KINASE 1 (CHK1) IN COMPLEX WITH REMARK 900 INHIBITORS REMARK 900 RELATED ID: 2WMT RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF CHECKPOINT KINASE 1 (CHK1) IN COMPLEX WITH REMARK 900 INHIBITORS REMARK 900 RELATED ID: 2WMU RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF CHECKPOINT KINASE 1 (CHK1) IN COMPLEX WITH REMARK 900 INHIBITORS REMARK 900 RELATED ID: 2WMV RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF CHECKPOINT KINASE 1 (CHK1) IN COMPLEX WITH REMARK 900 INHIBITORS REMARK 900 RELATED ID: 2WMW RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF CHECKPOINT KINASE 1 (CHK1) IN COMPLEX WITH REMARK 900 INHIBITORS REMARK 900 RELATED ID: 2WMX RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF CHECKPOINT KINASE 1 (CHK1) IN COMPLEX WITH REMARK 900 INHIBITORS REMARK 900 RELATED ID: 2X8D RELATED DB: PDB REMARK 900 DISCOVERY OF A NOVEL CLASS OF TRIAZOLONES AS CHECKPOINT KINASE REMARK 900 INHIBITORS - HIT TO LEAD EXPLORATION REMARK 900 RELATED ID: 2X8E RELATED DB: PDB REMARK 900 DISCOVERY OF A NOVEL CLASS OF TRIAZOLONES AS CHECKPOINT KINASE REMARK 900 INHIBITORS - HIT TO LEAD EXPLORATION REMARK 900 RELATED ID: 2X8I RELATED DB: PDB REMARK 900 DISCOVERY OF A NOVEL CLASS OF TRIAZOLONES AS CHECKPOINT KINASE REMARK 900 INHIBITORS - HIT TO LEAD EXPLORATION REMARK 900 RELATED ID: 2XEY RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF CHECKPOINT KINASE 1 (CHK1) IN COMPLEX WITH REMARK 900 INHIBITORS REMARK 900 RELATED ID: 2XEZ RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF CHECKPOINT KINASE 1 (CHK1) IN COMPLEX WITH REMARK 900 INHIBITORS REMARK 900 RELATED ID: 2XF0 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF CHECKPOINT KINASE 1 (CHK1) IN COMPLEX WITH REMARK 900 INHIBITORS REMARK 900 RELATED ID: 2YDI RELATED DB: PDB REMARK 900 DISCOVERY OF CHECKPOINT KINASE INHIBITOR AZD7762 BY STRUCTURE BASED REMARK 900 DESIGN AND OPTIMIZATION OF THIOPHENE CARBOXAMIDE UREAS REMARK 900 RELATED ID: 2YDJ RELATED DB: PDB REMARK 900 DISCOVERY OF CHECKPOINT KINASE INHIBITOR AZD7762 BY STRUCTURE BASED REMARK 900 DESIGN AND OPTIMIZATION OF THIOPHENE CARBOXAMIDE UREAS REMARK 900 RELATED ID: 2YDK RELATED DB: PDB REMARK 900 DISCOVERY OF CHECKPOINT KINASE INHIBITOR AZD7762 BY STRUCTURE BASED REMARK 900 DESIGN AND OPTIMIZATION OF THIOPHENE CARBOXAMIDE UREAS REMARK 900 RELATED ID: 2YEX RELATED DB: PDB REMARK 900 SYNTHESIS AND EVALUATION OF TRIAZOLONES AS CHECKPOINT KINASE 1 REMARK 900 INHIBITORS REMARK 900 RELATED ID: 2YM3 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF CHECKPOINT KINASE 1 (CHK1) IN COMPLEX WITH REMARK 900 INHIBITORS REMARK 900 RELATED ID: 2YM4 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF CHECKPOINT KINASE 1 (CHK1) IN COMPLEX WITH REMARK 900 INHIBITORS REMARK 900 RELATED ID: 2YM5 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF CHECKPOINT KINASE 1 (CHK1) IN COMPLEX WITH REMARK 900 INHIBITORS REMARK 900 RELATED ID: 2YM6 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF CHECKPOINT KINASE 1 (CHK1) IN COMPLEX WITH REMARK 900 INHIBITORS REMARK 900 RELATED ID: 2YM7 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF CHECKPOINT KINASE 1 (CHK1) IN COMPLEX WITH REMARK 900 INHIBITORS REMARK 900 RELATED ID: 2YM8 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF CHECKPOINT KINASE 1 (CHK1) IN COMPLEX WITH REMARK 900 INHIBITORS DBREF 2YER A 1 276 UNP O14757 CHK1_HUMAN 1 276 SEQRES 1 A 276 MET ALA VAL PRO PHE VAL GLU ASP TRP ASP LEU VAL GLN SEQRES 2 A 276 THR LEU GLY GLU GLY ALA TYR GLY GLU VAL GLN LEU ALA SEQRES 3 A 276 VAL ASN ARG VAL THR GLU GLU ALA VAL ALA VAL LYS ILE SEQRES 4 A 276 VAL ASP MET LYS ARG ALA VAL ASP CYS PRO GLU ASN ILE SEQRES 5 A 276 LYS LYS GLU ILE CYS ILE ASN LYS MET LEU ASN HIS GLU SEQRES 6 A 276 ASN VAL VAL LYS PHE TYR GLY HIS ARG ARG GLU GLY ASN SEQRES 7 A 276 ILE GLN TYR LEU PHE LEU GLU TYR CYS SER GLY GLY GLU SEQRES 8 A 276 LEU PHE ASP ARG ILE GLU PRO ASP ILE GLY MET PRO GLU SEQRES 9 A 276 PRO ASP ALA GLN ARG PHE PHE HIS GLN LEU MET ALA GLY SEQRES 10 A 276 VAL VAL TYR LEU HIS GLY ILE GLY ILE THR HIS ARG ASP SEQRES 11 A 276 ILE LYS PRO GLU ASN LEU LEU LEU ASP GLU ARG ASP ASN SEQRES 12 A 276 LEU LYS ILE SER ASP PHE GLY LEU ALA THR VAL PHE ARG SEQRES 13 A 276 TYR ASN ASN ARG GLU ARG LEU LEU ASN LYS MET CYS GLY SEQRES 14 A 276 THR LEU PRO TYR VAL ALA PRO GLU LEU LEU LYS ARG ARG SEQRES 15 A 276 GLU PHE HIS ALA GLU PRO VAL ASP VAL TRP SER CYS GLY SEQRES 16 A 276 ILE VAL LEU THR ALA MET LEU ALA GLY GLU LEU PRO TRP SEQRES 17 A 276 ASP GLN PRO SER ASP SER CYS GLN GLU TYR SER ASP TRP SEQRES 18 A 276 LYS GLU LYS LYS THR TYR LEU ASN PRO TRP LYS LYS ILE SEQRES 19 A 276 ASP SER ALA PRO LEU ALA LEU LEU HIS LYS ILE LEU VAL SEQRES 20 A 276 GLU ASN PRO SER ALA ARG ILE THR ILE PRO ASP ILE LYS SEQRES 21 A 276 LYS ASP ARG TRP TYR ASN LYS PRO LEU LYS LYS GLY ALA SEQRES 22 A 276 LYS ARG PRO HET TQ1 A1270 21 HET SO4 A1271 5 HET EDO A1272 4 HET EDO A1273 4 HET EDO A1274 4 HET EDO A1275 4 HET EDO A1276 4 HET EDO A1277 4 HETNAM TQ1 5-(HYDROXYMETHYL)-8-(1H-PYRROL-2-YL)-2H-[1,2, HETNAM 2 TQ1 4]TRIAZOLO[4,3-A]QUINOLIN-1-ONE HETNAM SO4 SULFATE ION HETNAM EDO 1,2-ETHANEDIOL HETSYN EDO ETHYLENE GLYCOL FORMUL 2 TQ1 C15 H12 N4 O2 FORMUL 3 SO4 O4 S 2- FORMUL 4 EDO 6(C2 H6 O2) FORMUL 10 HOH *407(H2 O) HELIX 1 1 ALA A 2 ASP A 8 1 7 HELIX 2 2 LYS A 43 ALA A 45 5 3 HELIX 3 3 ASP A 47 LEU A 62 1 16 HELIX 4 4 PHE A 93 ILE A 96 5 4 HELIX 5 5 PRO A 103 ILE A 124 1 22 HELIX 6 6 LYS A 132 GLU A 134 5 3 HELIX 7 7 THR A 170 VAL A 174 5 5 HELIX 8 8 ALA A 175 LYS A 180 5 6 HELIX 9 9 HIS A 185 GLY A 204 1 20 HELIX 10 10 CYS A 215 GLU A 223 1 9 HELIX 11 11 PRO A 230 ILE A 234 5 5 HELIX 12 12 ASP A 235 LEU A 246 1 12 HELIX 13 13 THR A 255 LYS A 260 1 6 SHEET 1 AA 5 TRP A 9 GLU A 17 0 SHEET 2 AA 5 GLU A 22 ASN A 28 -1 O VAL A 23 N LEU A 15 SHEET 3 AA 5 ALA A 34 ASP A 41 -1 O VAL A 35 N ALA A 26 SHEET 4 AA 5 ILE A 79 GLU A 85 -1 O GLN A 80 N VAL A 40 SHEET 5 AA 5 PHE A 70 GLU A 76 -1 N TYR A 71 O PHE A 83 SHEET 1 AB 3 GLY A 90 GLU A 91 0 SHEET 2 AB 3 LEU A 136 LEU A 138 -1 N LEU A 138 O GLY A 90 SHEET 3 AB 3 LEU A 144 ILE A 146 -1 O LYS A 145 N LEU A 137 SHEET 1 AC 2 ILE A 126 THR A 127 0 SHEET 2 AC 2 THR A 153 VAL A 154 -1 O THR A 153 N THR A 127 SHEET 1 AD 2 ARG A 156 TYR A 157 0 SHEET 2 AD 2 ARG A 160 GLU A 161 -1 O ARG A 160 N TYR A 157 CISPEP 1 ASN A 229 PRO A 230 0 0.40 SITE 1 AC1 11 LEU A 15 ALA A 36 GLU A 85 TYR A 86 SITE 2 AC1 11 CYS A 87 GLY A 90 GLU A 91 GLU A 134 SITE 3 AC1 11 LEU A 137 HOH A2248 HOH A2249 SITE 1 AC2 10 LYS A 54 ARG A 129 THR A 153 ARG A 162 SITE 2 AC2 10 LYS A 166 HOH A2098 HOH A2397 HOH A2398 SITE 3 AC2 10 HOH A2399 HOH A2400 SITE 1 AC3 5 ARG A 156 GLU A 161 GLU A 187 HOH A2401 SITE 2 AC3 5 HOH A2402 SITE 1 AC4 6 ARG A 74 ARG A 75 LYS A 232 LYS A 233 SITE 2 AC4 6 ILE A 234 ASP A 235 SITE 1 AC5 5 ASP A 94 ARG A 181 GLU A 183 HOH A2404 SITE 2 AC5 5 HOH A2405 SITE 1 AC6 6 GLU A 33 VAL A 35 TYR A 71 LYS A 225 SITE 2 AC6 6 TYR A 227 HOH A2406 SITE 1 AC7 3 PHE A 93 GLY A 204 GLU A 205 SITE 1 AC8 5 TRP A 221 LYS A 222 LYS A 224 HIS A 243 SITE 2 AC8 5 LEU A 246 CRYST1 41.160 69.920 103.500 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.024295 0.000000 0.000000 0.00000 SCALE2 0.000000 0.014302 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009662 0.00000